Has Nathan Saucier, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,339 in general payments to Nathan Saucier, MD across 366 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nathan Saucier, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nathan Saucier, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nathan Saucier, MD

Nephrology · New Bern, NCNPI 1760511646

Payments from drug & device makers

$21,339in general payments, 2019–2025

Across 366 payments — averaging $58.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Angiodynamics, Inc.$8K
Inari Medical, Inc.$3K
Medtronic$1K
Boston Scientific$1K
Nxstage Medical, Inc.$1K
Amgen$833
plus $5K from 40 others

What the payments were for

Consulting fees$2,54812%
Speaking & faculty fees$9044%
Travel & lodging$1,0065%
Food & beverage$8,52440%
Education$1621%
Other$8,19438%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Angiodynamics, Inc.	2	$8,194
Inari Medical, Inc.	13	$3,241
Medtronic	10	$1,400
Boston Scientific	78	$1,166
Nxstage Medical, Inc.	14	$1,165
Amgen(2 entities)	38	$833
GE HealthCare	2	$548
AstraZeneca(2 entities)	26	$503
Sanofi	3	$437
Vifor Pharma, Inc.	15	$408
Fresenius USA Marketing, Inc.	13	$389
Novartis	9	$360
Otsuka America Pharmaceutical, Inc.	16	$284
Travere Therapeutics, Inc.	13	$263
Aurinia Pharma U.S., Inc.	11	$256
Bard Peripheral Vascular, Inc.	10	$217
OPKO Pharmaceuticals, LLC	13	$201
Calliditas Therapeutics US Inc.	7	$185
Mallinckrodt Hospital Products Inc.	8	$162
Bayer	9	$139
GSK	6	$104
BD	4	$98
Ardelyx, Inc.	5	$97
Philips North America LLC	5	$76
Novo Nordisk	3	$60
Daiichi Sankyo Inc.	4	$59
Boehringer Ingelheim	3	$46
Takeda Pharmaceuticals U.S.A., Inc.	3	$45
ANI Pharmaceuticals, Inc.	2	$35
Merck	2	$31
Cardiovascular Systems Inc.	2	$29
Biomerieux Inc	1	$29
Cormedix Inc.	1	$29
Cook Medical LLC	2	$28
Akebia Therapeutics Inc	2	$26
Kyowa Kirin, Inc.	1	$24
W. L. Gore & Associates, Inc.	1	$23
Ultragenyx Pharmaceutical Inc.	1	$23
Mallinckrodt Enterprises LLC	1	$20
Baudax Bio Inc.	1	$18
Veloxis Pharmaceuticals, Inc.	1	$17
Global Blood Therapeutics, Inc.	1	$16
Lilly USA, LLC	1	$16
Covidien LP	1	$16
Xeris Pharmaceuticals, Inc.	1	$12
Tactile Systems Technology Inc	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,339 in reported general payments places this provider in the 80th percentile of 366 nephrology providers in North Carolina.

See all nephrology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$765,940

Medicare patients

384

Services billed

15,887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisone	38	$49

Paid to pharmacies, not to this prescriber.

Other nephrology in New Bern

Manuel MonteroNew Bern$2.5M
Stuart JenningsNew Bern$40K
Daniel EdmonstonDurham$9.9M
Gregory GreenwoodWinston-Salem$4.1M
Barry FreedmanWinston Salem$3.5M
Rekha JohnKinston$2.3M
Nauman ShahidGreenville$2M
Eric KirkWilmington$1.7M
Amy MottlSanford$1.6M
Amarnath KathresalDurham$1.6M

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →